Development of a strategic tool for shared decision-making in the use of antidepressants among patients with major depressive disorder: A focus group study
Shared decision-making (SDM) has been recognized as an important tool in the mental health field and considered as a crucial component of patient-centered care. Therefore, the purpose of this study was to develop a strategic tool towards the promotion and implementation of SDM in the use of antid...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
Multidisciplinary Digital Publishing Institute (MDPI)
2018
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/66505/1/66505_Development%20of%20a%20Strategic%20Tool%20for%20Shared_article.pdf http://irep.iium.edu.my/66505/2/66505_Development%20of%20a%20Strategic%20Tool%20for%20Shared_scopus.pdf http://irep.iium.edu.my/66505/ https://www.mdpi.com/1660-4601/15/7/1402/htm |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universiti Islam Antarabangsa Malaysia |
| Language: | English English |
| Summary: | Shared decision-making (SDM) has been recognized as an important tool in the mental
health field and considered as a crucial component of patient-centered care. Therefore, the purpose of
this study was to develop a strategic tool towards the promotion and implementation of SDM in the
use of antidepressants among patients with major depressive disorder. Nineteen doctors and 11 major
depressive disorder patients who are involved in psychiatric outpatient clinic appointments were
purposively selected and recruited to participate in one of six focus groups in a large teaching hospital
in Malaysia. Focus groups were transcribed verbatim and analyzed using a thematic approach to
identify current views on providing information needed for SDM practice towards its implementation
in near future. Patients’ and doctors’ views were organized into six major themes, which are; summary
of treatment options, correct ways of taking medication, potential side effects of treatments related to
patients, sharing of case study related to the treatment options, cost of treatment options, and input
from pharmacist. The information may be included in the SDM tool which can be useful to inform
further research efforts and developments that contribute towards the successful implementation of
SDM into clinical practice. |
|---|